These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 8318553)

  • 21. Experimental model of escape phenomenon in hamsters and the effectiveness of YM-53601 in the model.
    Ugawa T; Kakuta H; Moritani H; Shikama H
    Br J Pharmacol; 2002 Mar; 135(6):1572-8. PubMed ID: 11906972
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Plasma lipoprotein changes after treatment with pravastatin and gemfibrozil in patients with familial hypercholesterolemia.
    Franceschini G; Sirtori M; Vaccarino V; Gianfranceschi G; Chiesa G; Sirtori CR
    J Lab Clin Med; 1989 Sep; 114(3):250-9. PubMed ID: 2504855
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pravastatin decreases serum lipids and vascular cholesterol deposition in Watanabe heritable hyperlipidemic (WHHL) rabbits.
    Khachadurian AK; Shimamura T; Rozovski SJ; Ananthakrishnan R; Armenian B; Coly E; alHinai A; Martucci C; Schneider SH; Amorosa LF
    Jpn Heart J; 1991 Sep; 32(5):675-85. PubMed ID: 1774829
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Comparison of the effectiveness of the HMG-CoA-reductase inhibitors pravastatin versus colestyramine in hypercholesteremia].
    Schwartzkopff W; Bimmermann A; Schleicher J
    Arzneimittelforschung; 1990 Dec; 40(12):1322-7. PubMed ID: 2128866
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of cigarette smoke and dietary cholesterol on plasma lipoprotein composition.
    Hojnacki JL; Mulligan JJ; Cluette JE; Kew RR; Stack DJ; Huber GL
    Artery; 1981; 9(4):285-304. PubMed ID: 7316779
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pravastatin: a new drug for the treatment of hypercholesterolemia.
    Jungnickel PW; Cantral KA; Maloley PA
    Clin Pharm; 1992 Aug; 11(8):677-89. PubMed ID: 1511541
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pravastatin reduces thrombogenicity by mechanisms beyond plasma cholesterol lowering.
    Casani L; Sanchez-Gomez S; Vilahur G; Badimon L
    Thromb Haemost; 2005 Nov; 94(5):1035-41. PubMed ID: 16363247
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Subcutaneous administration of HMG-CoA reductase inhibitors in hyperlipidaemic and normal rats.
    Joles J; Willekes-Koolschijn N; Koomans H; Van Tol A; Geelhoed-Mieras T; Crommelin D; Van Bloois L; Krajnc-Franken M; Cohen L; Griffioen M
    Lab Anim; 1992 Oct; 26(4):269-80. PubMed ID: 1447905
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dietary counseling is associated with an improved lipid profile in children with familial hypercholesterolemia.
    Torvik K; Narverud I; Ottestad I; Svilaas A; Gran JM; Retterstøl K; Ellingvåg A; Strøm E; Ose L; Veierød MB; Holven KB
    Atherosclerosis; 2016 Sep; 252():21-27. PubMed ID: 27494447
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy and short-term effects of pravastatin, a potent inhibitor of HMG-Co A reductase, on hypercholesterolemia in climacteric women.
    Ushiroyama T; Ikeda A; Ueki M; Sugimoto O
    J Med; 1994; 25(5):319-31. PubMed ID: 7730737
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Combination therapy with cilostazol and pravastatin improves antiatherogenic effects in low-density lipoprotein receptor knockout mice.
    Park KY; Heo TH
    Cardiovasc Ther; 2018 Dec; 36(6):e12476. PubMed ID: 30378752
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Simvastatin and pravastatin equally improve flow-mediated dilation in males with hypercholesterolemia.
    Sebestjen M; Boh M; Keber I
    Wien Klin Wochenschr; 2002 Dec; 114(23-24):999-1003. PubMed ID: 12635468
    [TBL] [Abstract][Full Text] [Related]  

  • 33. HMG-CoA reductase inhibitor (Statin) therapy and coronary atherosclerosis in Japanese subjects: role of high-density lipoprotein cholesterol.
    Tani S; Nagao K; Hirayama A
    Am J Cardiovasc Drugs; 2011 Dec; 11(6):411-7. PubMed ID: 22149320
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of CS-514, a new inhibitor of HMG CoA reductase, on plasma lipids, lipoproteins and apoproteins in patients with primary hypercholesterolemia.
    Kazumi T; Yoshino G; Kasama T; Iwatani I; Iwai M; Morita S; Baba S
    Horm Metab Res; 1986 Sep; 18(9):654-5. PubMed ID: 3096862
    [No Abstract]   [Full Text] [Related]  

  • 35. Effects of long-term treatment with low-dose pravastatin on biliary lipid and bile acid composition in patients with nonfamilial hyperlipoproteinemia.
    Tazuma S; Takizawa I; Kunita T; Mizuno T; Watanabe T; Teramen K; Horikawa K; Ochi H; Yamashita Y; Aihara N
    Metabolism; 1995 Nov; 44(11):1410-2. PubMed ID: 7476326
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Apolipoprotein(a) polymorphism predicts the increase of Lp(a) by pravastatin in patients with familial hypercholesterolaemia treated with bile acid sequestration.
    Klausen IC; Gerdes LU; Meinertz H; Hansen FA; Faergeman O
    Eur J Clin Invest; 1993 Apr; 23(4):240-5. PubMed ID: 8500516
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of low-dose pravastatin sodium on plasma cholesterol levels and aortic atherosclerosis of heterozygous WHHL rabbits fed a low cholesterol (0.03%) enriched diet for one year.
    Harsch M; Braesen JH; Niendorf A
    Atherosclerosis; 1997 Feb; 128(2):139-47. PubMed ID: 9050770
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cholesterol-lowering independent regression and stabilization of atherosclerotic lesions by pravastatin and by antimonocyte chemoattractant protein-1 therapy in nonhuman primates.
    Kitamoto S; Nakano K; Hirouchi Y; Kohjimoto Y; Kitajima S; Usui M; Inoue S; Egashira K
    Arterioscler Thromb Vasc Biol; 2004 Aug; 24(8):1522-8. PubMed ID: 15178560
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lifibrol as a model compound for a novel lipid-lowering mechanism of action.
    Berthold HK; Sudhop T; von Bergmann K; Gouni-Berthold I
    J Cardiovasc Pharmacol Ther; 2010 Dec; 15(4):364-72. PubMed ID: 20693157
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Characterization of plasma lipoproteins of grain- and cholesterol-fed White Carneau and Show Racer pigeons.
    Barakat HA; St Clair RW
    J Lipid Res; 1985 Oct; 26(10):1252-68. PubMed ID: 4067419
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.